Toronto (1)

Estrogen Receptor Positive and HER2 Negative Breast Cancer (1)

Microsatellite Stable Colorectal Carcinoma (1)

Platinum Resistant Epithelial Ovarian Cancer Type II (1)

Completed (1)

phase 2 (1)

University Health Network, Toronto (1)

azacitidine (1)

durvalumab (1)

drug (1)

Other (1)

Interventional (1)

platinum resistant epithelial ovarian cancer type ii

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Completed

Mar 30, 2021